Bridge Creek Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.88M | Buy |
22,383
+675
| +3% | +$55.6K | 0.52% | 65 |
|
|
2025
Q2 | $1.72M | Buy |
21,708
+705
| +3% | +$56K | 0.5% | 66 |
|
|
2025
Q1 | $1.89M | Buy |
21,003
+760
| +4% | +$71K | 0.59% | 63 |
|
|
2024
Q4 | $2.01M | Sell |
20,243
-35
| -0.2% | -$3.61K | 0.62% | 65 |
|
|
2024
Q3 | $2.3M | Hold |
20,278
| – | – | 0.69% | 61 |
|
|
2024
Q2 | $2.51M | Sell |
20,278
-440
| -2% | -$56.7K | 0.81% | 58 |
|
|
2024
Q1 | $2.73M | Sell |
20,718
-85
| -0.4% | -$10.5K | 0.88% | 51 |
|
|
2023
Q4 | $2.27M | Sell |
20,803
-55
| -0.3% | -$5.71K | 0.79% | 58 |
|
|
2023
Q3 | $2.15M | Sell |
20,858
-155
| -0.7% | -$16.7K | 0.81% | 54 |
|
|
2023
Q2 | $2.42M | Sell |
21,013
-332
| -2% | -$37.7K | 0.87% | 51 |
|
|
2023
Q1 | $2.27M | Buy |
21,345
+125
| +0.6% | +$13.5K | 0.85% | 53 |
|
|
2022
Q4 | $2.35M | Buy |
21,220
+109
| +0.5% | +$11.1K | 0.92% | 54 |
|
|
2022
Q3 | $1.82M | Sell |
21,111
-80
| -0.4% | -$7.14K | 0.78% | 54 |
|
|
2022
Q2 | $1.93M | Sell |
21,191
-874
| -4% | -$77.5K | 0.79% | 55 |
|
|
2022
Q1 | $1.81M | Buy |
22,065
+1,000
| +5% | +$78.8K | 0.6% | 60 |
|
|
2021
Q4 | $1.61M | Sell |
21,065
-563
| -3% | -$44.8K | 0.54% | 59 |
|
|
2021
Q3 | $1.62M | Buy |
21,628
+1,901
| +10% | +$145K | 0.59% | 57 |
|
|
2021
Q2 | $1.53M | Buy |
19,727
+91
| +0.5% | +$6.77K | 0.57% | 58 |
|
|
2021
Q1 | $1.44M | Buy |
19,636
+8,698
| +80% | +$642K | 0.55% | 60 |
|
|
2020
Q4 | $854K | Buy |
10,938
+2,931
| +37% | +$224K | 0.35% | 67 |
|
|
2020
Q3 | $634K | Buy |
8,007
+1,525
| +24% | +$119K | 0.3% | 70 |
|
|
2020
Q2 | $478K | Hold |
6,482
| – | – | 0.24% | 77 |
|
|
2020
Q1 | $475K | Hold |
6,482
| – | – | 0.28% | 75 |
|
|
2019
Q4 | $563K | Buy |
6,482
+501
| +8% | +$41.1K | 0.25% | 73 |
|
|
2019
Q3 | $480K | Sell |
5,981
-92
| -2% | -$7.37K | 0.23% | 74 |
|
|
2019
Q2 | $486K | Buy |
6,073
+78
| +1% | +$5.97K | 0.24% | 75 |
|
|
2019
Q1 | $476K | Sell |
5,995
-225
| -4% | -$16.8K | 0.24% | 69 |
|
|
2018
Q4 | $453K | Sell |
6,220
-26
| -0.4% | -$1.83K | 0.26% | 69 |
|
|
2018
Q3 | $422K | Sell |
6,246
-288
| -4% | -$18.3K | 0.21% | 71 |
|
|
2018
Q2 | $378K | Buy |
6,534
+12
| +0.2% | +$677 | 0.2% | 72 |
|
|
2018
Q1 | $339K | Buy |
6,522
+288
| +5% | +$15.6K | 0.18% | 73 |
|
|
2017
Q4 | $334K | Buy |
6,234
+367
| +6% | +$20.3K | 0.17% | 75 |
|
|
2017
Q3 | $358K | Buy |
5,867
+917
| +19% | +$55.6K | 0.19% | 72 |
|
|
2017
Q2 | $303K | Buy |
4,950
+419
| +9% | +$25.5K | 0.16% | 72 |
|
|
2017
Q1 | $275K | Buy |
4,531
+420
| +10% | +$25.5K | 0.15% | 73 |
|
|
2016
Q4 | $231K | Sell |
4,111
-3,090
| -43% | -$181K | 0.13% | 74 |
|
|
2016
Q3 | $429K | Sell |
7,201
-54
| -0.7% | -$3.16K | 0.25% | 64 |
|
|
2016
Q2 | $399K | Buy |
7,255
+157
| +2% | +$8.36K | 0.24% | 64 |
|
|
2016
Q1 | $358K | Sell |
7,098
-210
| -3% | -$10.3K | 0.21% | 70 |
|
|
2015
Q4 | $368K | Buy |
+7,308
| New | +$368K | 0.22% | 69 |
|
Other funds holding MRK
Bridge Creek Capital Management's MRK Position: Q3 2025 in Review
Bridge Creek Capital Management increased its Merck (MRK) stake by 3.1% in Q3 2025, buying an estimated $55.6K and bringing the position to 22,383 shares worth $1.88M. The position accounts for 0.52% of the portfolio, ranked #65.
Bridge Creek Capital Management first reported a position in MRK in Q4 2015 and has held it in 40 quarters since. The position peaked at $2.73M in Q1 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.
- Bridge Creek Capital Management held 22,383 shares of Merck worth $1.88M as of Q3 2025.
- Bridge Creek Capital Management bought 675 Merck shares in Q3 2025, an estimated $55.6K.
- Merck made up 0.52% of Bridge Creek Capital Management's portfolio in Q3 2025, its #65 holding.
- Bridge Creek Capital Management first reported a position in Merck in Q4 2015 and has held it in 40 quarters since.
- Bridge Creek Capital Management's Merck position peaked at $2.73M in Q1 2024.
- 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.
Based on Bridge Creek Capital Management's 13F filing for Q3 2025, filed 14 Oct 2025.